Connect your AI

Inogen INGN Change in Lease Liabilities

Change in Lease Liabilities at other companies

AdaptHealthAHCO

-$10.3M-31.0%

Pulmonx CorporationLUNG

-$329K-789%

Other financials

Income statement

Revenue$85.1M+3.4%

Gross profit$44.9M+1.7%

Operating income-$9.3M-21.9%

Net income-$8.3M-34.8%

EPS (diluted)-$0.30-20.0%

Balance sheet

Cash & equivalents$93.1M-21.7%

Total debt$16.9M-11.9%

Total equity$182.9M-7.6%

Total assets$285.9M-7.3%

Cash flow

Operating cash flow-$6.7M+60.2%

CapEx$210.0K-28.1%

Free cash flow-$6.9M+59.6%

Valuation

Market cap$174.63M-9.7%

Enterprise value$98.45M-9.5%

P/S0.5×-0.1×

Profitability

Gross margin52.8%-2.6pp

Operating margin-9.1%-0.8pp

Net margin-7.1%-0.8pp

FCF margin0.4%—

Returns & leverage

Return on equity-13.1%-0.9pp

Debt / equity0.1×0.0×

Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Inogen's change in lease liabilities?: Inogen (INGN) reported change in lease liabilities of -$573K in Q1 2026.
How has Inogen's change in lease liabilities changed year-over-year?: Inogen's change in lease liabilities increased by 24.7% year-over-year, from -$761K to -$573K.
What is the long-term trend for Inogen's change in lease liabilities?: Over 3 years (2022 to 2025), Inogen's change in lease liabilities has grown at a -0.9% compound annual growth rate (CAGR), from -$3.4M to -$3.31M.
What does change in lease liabilities mean?: Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.